0000000001079055

AUTHOR

José Juan Pozo-kreilinger

showing 4 related works from this author

Expression of clec9a in the oral cancer microenvironment. A preliminary immunohistochemical pilot study

2021

Background The search for treatments to improve cancer survival has led to the emergence of immunotherapy and the study of the tumour microenvironment existing in neoplasms. This preliminary study aims to understand the clinical and pathological relationship of clec9a expression in oral cancer and to explore survival models for future studies. Material and methods: Immunohistochemical study that included 26 patients with a diagnosis of oral squamous cell carcinoma (OSCC) in mobile tongue and floor of the mouth. Clinical and histopathological variables were recorded, and the biomarkers clec9a for dendritic cells and CD8 and CD4 for lymphocytes were used. Results Clec9a was expressed in 58% o…

Oncologymedicine.medical_specialtymedicine.medical_treatmentPilot ProjectsInternal medicineOral Cancer and Potentially malignant disordersmedicineCarcinomaTumor MicroenvironmentHumansLectins C-TypepainGeneral DentistryPathologicalSurvival analysisUNESCO:CIENCIAS MÉDICASMouth neoplasmTumor microenvironmentbusiness.industryResearchquestionnaireCancerpsychometric validationImmunotherapymedicine.diseasePrognosisstomatognathic diseasesOtorhinolaryngologydisabilityHead and Neck NeoplasmsReceptors MitogenCarcinoma Squamous CellImmunohistochemistrySurgeryMouth Neoplasmshead and neck cancerbusiness
researchProduct

Dental implants rehabilitation in a patient with head and neck radiotherapy for osteosarcoma in the jaw. A clinical case report

2021

A 52-year-old female patient with a diagnostic of osteosarcoma in the mandible, in which it was necessary a reconstruction with a microvascularized osteomyocutaneous fibula bone. Coadjuvant chemotherapy was scheduled. Two years later, 4 osseointegrated implants (OII) were placed in the fibula a 2 OII in the right mandible, using a splint guided surgery. The final prosthodontic consisted in a metal ceramic restoration using CAD/ CAM technology. Key words:Oral rehabilitation, oral cancer, head and neck radiotherapy, oral oncology.

oral oncologyMedicinamedicine.medical_treatmentDentistryCase ReportOsseointegration03 medical and health sciences0302 clinical medicineHead and neck radiotherapymedicineOral rehabilitationFibulaGeneral DentistryUNESCO:CIENCIAS MÉDICASRehabilitationbusiness.industryMandible030206 dentistryoral cancermedicine.diseasehead and neck radiotherapy030220 oncology & carcinogenesisOsteosarcomaClinical caseOral SurgerySplint (medicine)businessJournal of Clinical and Experimental Dentistry
researchProduct

Jaw in a day: Osseointegration of the implants in the patient’s leg before reconstructive surgery of a maxilla with ameloblastoma. A 4-year follow-up…

2021

Background To describe a clinical case of a cancer patient who underwent ablative tumor surgery, including treatment planning, surgical resection and subsequent implant rehabilitation. Case report A 61-year-old patient with a diagnosis of multicystic follicular ameloblastoma in the maxilla, in which it was necessary a multidisciplinary approach and two surgical steps. In the first surgical intervention osseointegrated implants (OII) were placed in the fibula, until their osseointegration period of 8 weeks was complete. Afterwards, in the second surgery, the micro-vascularized free fibular flap bearing the implants was transplanted into the oral cavity, in order to perform simultaneous recon…

medicine.medical_specialtyReconstructive surgeryMedicinamedicine.medical_treatmentCase ReportProsthesisOsseointegration03 medical and health sciences0302 clinical medicineMedicineOral rehabilitationRadiation treatment planningGeneral DentistryUNESCO:CIENCIAS MÉDICASRehabilitationbusiness.industry030206 dentistryoral cancerSurgeryStomatognathic system030220 oncology & carcinogenesisMaxillaImplantOral Surgerybusinessoral surgeryJournal of Clinical and Experimental Dentistry
researchProduct

Oral mucositis. Is it present in the immunotherapy of the immune checkpoint pd1/pd-l1 against oral cancer? A systematic review

2020

Background Oral mucositis (OM) is a painful lesion that takes place in the mucosa of the oral cavity, usually its etiology is associated with drug therapies in cancer patients. It is presented as well-defined ulcers whose painful symptomatology sometimes implies the suspension of oncological treatment or parenteral feeding, being therefore an important adverse effect, marking the evolution of these types of therapies against cancer. The present work aim is to know the prevalence of oral mucositis in oral cancer immunotherapy compared to its prevalence in standard therapy. Material and Methods A protocol was developed for a systematic review following PRISMA® guidelines and a focused questio…

Oncologymedicine.medical_specialtymedicine.medical_treatmentReviewPembrolizumabB7-H1 Antigenperiapical lesionInternal medicinedifferential diagnosisMucositisHumansMedicineAdverse effectGeneral DentistryUNESCO:CIENCIAS MÉDICASStomatitisOral Medicine and PathologyCetuximabbusiness.industryCancerImmunotherapymedicine.diseasepulp necrosisClinical trialNivolumabOtorhinolaryngologynonendodonticMouth NeoplasmsSurgeryImmunotherapyNivolumabbusinessmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct